NO882037L - Famotidin, polymerte former og fremstilling derav. - Google Patents

Famotidin, polymerte former og fremstilling derav.

Info

Publication number: NO882037L
Authority: NO; Norway
Prior art keywords: famotidine; manufacturing; polymeric forms; preparation; melting point
Prior art date: 1987-06-22

Application number

NO882037A

Other languages

English (en)

Other versions

NO882037D0 (no

Inventor

Montserrat Ballester-Rodes

Francisco Eugen Palomo-Nicolau

Antonio Luis Palomo-Coll

Original Assignee

Marga Para La Investigacion Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-22

Filing date

1988-05-10

Publication date

1988-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27240404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO882037(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-06-22 Priority claimed from ES8702020A external-priority patent/ES2009147A6/es

1987-10-29 Priority claimed from ES8703326A external-priority patent/ES2015339A6/es

1988-03-23 Priority claimed from ES8800888A external-priority patent/ES2017246A6/es

1988-05-10 Application filed by Marga Para La Investigacion Sa filed Critical Marga Para La Investigacion Sa

1988-05-10 Publication of NO882037D0 publication Critical patent/NO882037D0/no

1988-12-23 Publication of NO882037L publication Critical patent/NO882037L/no

Links

XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 title abstract 2
229960001596 famotidine Drugs 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
230000008018 melting Effects 0.000 abstract 2
238000002844 melting Methods 0.000 abstract 2
230000004071 biological effect Effects 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Compositions Of Macromolecular Compounds (AREA)
Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Thiazole And Isothizaole Compounds (AREA)
Electron Beam Exposure (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Pyridine Compounds (AREA)
Saccharide Compounds (AREA)

NO882037A 1987-06-22 1988-05-10 Famotidin, polymerte former og fremstilling derav. NO882037L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ES8702020A ES2009147A6 (es)	1987-06-22	1987-06-22	Nuevo proceso para la preparacion de polimorfos de famotidina
ES8703326A ES2015339A6 (es)	1987-10-29	1987-10-29	Perfeccionamientos a la patente de invencion numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.
ES8800888A ES2017246A6 (es)	1988-03-23	1988-03-23	Mejoras a la patente de invencion, numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.

Publications (2)

Publication Number	Publication Date
NO882037D0 NO882037D0 (no)	1988-05-10
NO882037L true NO882037L (no)	1988-12-23

Family

ID=27240404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882037A NO882037L (no)	1987-06-22	1988-05-10	Famotidin, polymerte former og fremstilling derav.

Country Status (13)

Country	Link
US (1)	US5021582A (no)
EP (1)	EP0297019B1 (no)
JP (1)	JPH01100162A (no)
KR (1)	KR920000308B1 (no)
CN (1)	CN1030077A (no)
AT (1)	ATE69052T1 (no)
AU (1)	AU1767288A (no)
CA (1)	CA1322760C (no)
DE (1)	DE3865899D1 (no)
DK (1)	DK342988A (no)
FI (1)	FI882329A7 (no)
IL (1)	IL86330A0 (no)
NO (1)	NO882037L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU196775B (en) *	1986-08-05	1989-01-30	Richter Gedeon Vegyeszet	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
US5631023A (en) *	1993-07-09	1997-05-20	R.P. Scherer Corporation	Method for making freeze dried drug dosage forms
EP0844997A1 (en) *	1996-06-19	1998-06-03	Dr. Reddy's Research Foundation	Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
RU2192251C1 (ru) *	2001-05-25	2002-11-10	Дальневосточный государственный медицинский университет	Способ снижения гликемии у больных сахарным диабетом ii типа с гастродуоденальными язвами
JP4755789B2 (ja) *	2001-09-26	2011-08-24	株式会社フジシールインターナショナル	ラベル及びその製造方法
CA2426122A1 (en) *	2002-05-02	2003-11-02	M/S Tonira Pharma Limited	A process for the preparation of a combination of famotidine polymorphis a and b
US8058296B2 (en) *	2008-11-25	2011-11-15	Richard Tokunaga	Treatment and prevention of deleterious effects associated with alcohol consumption
CN117534630B (zh) *	2022-08-02	2025-11-18	重庆世森医药科技有限公司	一种高纯度法莫替丁精制得b晶型的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4496737A (en) *	1982-09-27	1985-01-29	Merck & Co., Inc.	Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) *	1983-06-07	1984-12-21	Yamanouchi Pharmaceut Co Ltd	新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) *	1985-09-11	1988-03-28	Richter Gedeon Vegyeszet	Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) *	1986-06-20	1987-12-23	Uriach & Cia Sa J	Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
HU196775B (en) *	1986-08-05	1989-01-30	Richter Gedeon Vegyeszet	Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

1988
- 1988-05-10 IL IL86330A patent/IL86330A0/xx unknown
- 1988-05-10 NO NO882037A patent/NO882037L/no unknown
- 1988-05-18 FI FI882329A patent/FI882329A7/fi not_active Application Discontinuation
- 1988-05-23 US US07/197,329 patent/US5021582A/en not_active Expired - Fee Related
- 1988-05-25 CN CN88103190A patent/CN1030077A/zh active Pending
- 1988-05-31 JP JP63134279A patent/JPH01100162A/ja active Pending
- 1988-06-01 DE DE8888500054T patent/DE3865899D1/de not_active Revoked
- 1988-06-01 EP EP88500054A patent/EP0297019B1/en not_active Expired - Lifetime
- 1988-06-01 AT AT88500054T patent/ATE69052T1/de not_active IP Right Cessation
- 1988-06-14 AU AU17672/88A patent/AU1767288A/en not_active Abandoned
- 1988-06-20 KR KR1019880007442A patent/KR920000308B1/ko not_active Expired
- 1988-06-21 CA CA000569954A patent/CA1322760C/en not_active Expired - Fee Related
- 1988-06-22 DK DK342988A patent/DK342988A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE3865899D1 (de)	1991-12-05
CA1322760C (en)	1993-10-05
EP0297019A1 (en)	1988-12-28
FI882329A7 (fi)	1988-12-23
DK342988A (da)	1988-12-23
KR920000308B1 (ko)	1992-01-11
US5021582A (en)	1991-06-04
IL86330A0 (en)	1988-11-15
EP0297019B1 (en)	1991-10-30
ATE69052T1 (de)	1991-11-15
DK342988D0 (da)	1988-06-22
CN1030077A (zh)	1989-01-04
KR890000086A (ko)	1989-03-11
FI882329A0 (fi)	1988-05-18
NO882037D0 (no)	1988-05-10
JPH01100162A (ja)	1989-04-18
AU1767288A (en)	1988-12-22

Similar Documents

Publication	Publication Date	Title
IT8819213A0 (it)	1988-01-26	Procedimento e dispositivo per la realizzazione di mescole di caucciu'.
IT8522494A0 (it)	1985-10-15	Procedimento per la preparazione di formulazioni solide di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute.
DE3750431D1 (de)	1994-09-29	Stabilisiertes Arzneimittel und dessen Herstellung.
IT8322425A0 (it)	1983-08-04	Procedimento per la preparazione di solfato di bario con fluidita' e densita' accresciute, adatto quale componente opacizzante nei mezzi di contrasto, prodotto ottenuto con questo procedimento e relativi mezzi di contrasto allestiti.
PH22556A (en)	1988-10-17	Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof
DE3876400D1 (de)	1993-01-14	Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
NO853466L (no)	1986-03-05	Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
NO882037L (no)	1988-12-23	Famotidin, polymerte former og fremstilling derav.
IT8522668A0 (it)	1985-10-30	Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti.
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
IT8403511A0 (it)	1984-06-29	Procedimento per la preparazione di etofibrato o sostanze di pari osimili caratteristiche, inmicrogranuli-ritardo e prodotto ottenuto con tale procedimento
DE3778924D1 (de)	1992-06-17	Pyridazinon-derivate, deren herstellung und insektizide, akarizide, nematizide, fungizide zusammenstellungen.
DE3778089D1 (de)	1992-05-14	Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
IT8321727A0 (it)	1983-06-21	Procedimento per la fabbricazione di corpi tubolari flessibili, dispositivo per l'attuazione ditale procedimento e corpi flessibili ottenuti.
ATE100095T1 (de)	1994-01-15	2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
NO870104D0 (no)	1987-01-12	Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
FR2666334B1 (fr)	1994-09-16	Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
IT8620121A0 (it)	1986-04-17	Nuovo procedimento chimico per lapreparazione di derivati dell'ossamide e composti cosi'ottenuti.
NO881768L (no)	1988-10-25	Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE69021599D1 (de)	1995-09-21	Biologisch aktive RON-Substanz Synthetase und ihre Verwendung für die Herstellung biologisch aktiver RON-Substanz.
BG60271B1 (bg)	1994-03-31	13-алкил-23-имино и 13-хало-23-имино производни на ll-f28249 и приложението им като ендо- и ектопаразитицидни, инсектицидни, акарицидни и нематоцидни средства
DE3874422D1 (de)	1992-10-15	Feldeffekttransistor mit kurzer kanallaenge und verfahren zu dessen herstellung.
IT8722553A0 (it)	1987-11-06	Procedimento per la fabbricazione di corpi tubolari leggeri e corpo tubolare ottenuto tramite detto procedimento.
DE3888697D1 (de)	1994-04-28	2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it